FLXN - Flexion Therapeutics Inc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - FLXN (1419600)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
26 results - Yahoo - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2020-05-26
FLXNStejbach MarkDirP - Purchase$9.75+2,0513,631+130%+$19,997
2020-05-26
FLXNClayman Michael D.Pres, CEOP - Purchase$9.75+10,256824,845+1%+$99,996
2020-05-07
FLXNArkowitz DavidCFOS - Sale$10.88-2,413117,068-2%-$26,253
2020-01-03
FLXNWillwerth ChristinaChief Strategy OfficerS - Sale$0.00-3,53352,473-6%-$0
2020-01-03
FLXNKelley ScottChief Medical OfficerS - Sale$0.00-3,72449,365-7%-$0
2020-01-03
FLXNLevine Mark S.GCS - Sale$0.00-3,72443,487-8%-$0
2020-01-03
FLXNWentworth KerryChief Regulatory OfficerS - Sale$0.00-3,72456,061-6%-$0
2020-01-03
FLXNArkowitz DavidCFOS - Sale$0.00-3,09588,481-3%-$0
2020-01-03
FLXNBodick NeilChief Scientific OfficerS - Sale$0.00-3,851489,836-1%-$0
2019-08-08
FLXNColella Samuel DDir, 10%P - Purchase$10.74+2,0003,996,9290%+$21,480
2019-08-08
FLXNClayman Michael D.Pres, CEOP - Purchase$10.85+2,317806,0260%+$25,136
2019-05-31
FLXNArkowitz DavidCFOP - Purchase$11.05+2,50089,424+3%+$27,627
2019-05-23
FLXNMerrifield C AnnDirP - Purchase$12.64+8,00010,000+400%+$101,120
2019-05-13
FLXNArkowitz DavidCFOP - Purchase$11.99+4,00086,924+5%+$47,960
2019-05-10
FLXNClayman Michael D.Pres, CEOP - Purchase$12.48+4,012802,217+1%+$50,067
2019-05-08
FLXNArkowitz DavidCFOS - Sale$10.06-2,24882,924-3%-$22,615
2019-03-12
FLXNClayman Michael D.Pres, CEOP - Purchase$12.36+4,046798,205+1%+$50,009
2019-01-03
FLXNLevine Mark S.GCS - Sale$12.36-7349,060-7%-$9,072
2019-01-03
FLXNWentworth KerryChief Regulatory OfficerS - Sale$12.36-62217,207-3%-$7,688
2019-01-03
FLXNKelley ScottChief Medical OfficerS - Sale$12.36-62215,271-4%-$7,688
2019-01-03
FLXNBodick NeilChief Scientific OfficerS - Sale$12.36-746454,4650%-$9,221
2019-01-03
FLXNClayman Michael D.Pres, CEOS - Sale$12.36-3,278794,1590%-$40,516
2018-11-09
FLXNClayman Michael D.Pres, CEOP - Purchase$17.10+5,000796,515+1%+$85,477
2018-11-09
FLXNArkowitz DavidCFOP - Purchase$16.56+4,00048,250+9%+$66,222
2018-08-09
FLXNArkowitz DavidCFOP - Purchase$23.42+4,00044,250+10%+$93,680
2018-08-09
FLXNClayman Michael D.Pres, CEOP - Purchase$22.33+10,000782,948+1%+$223,300
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top